secwatch.observer — SEC 8-K summary
======================================

Issuer:     CONMED Corp (CNMD)
CIK:        0000816956
Form:       8-K
Filed at:   2025-02-25T23:59:59+00:00
Accession:  0001174947-25-000234
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CONMED appoints Mark Kaye as director; declares $0.20 quarterly dividend
------------------------------------------------------------------------

- Board expanded to nine; Mark Kaye appointed effective Feb 24, 2025, with Audit and Strategy committee assignments.
- Quarterly dividend of $0.20 per share declared, payable April 4, 2025 to holders of record March 14, 2025.
- Kaye currently EVP & CFO of Elevance Health; previously CFO of Moody's and senior finance roles at MassMutual and ING.
- Kaye received prorated equity grant of 152 RSUs and options on 1,846 shares, vesting in full on Feb 24, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/816956/000117494725000234/0001174947-25-000234-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/816956/000117494725000234/form8k-33666_cnmd.htm
  HTML page:      https://secwatch.observer/filing/0001174947-25-000234

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer